Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion type Assertion NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_head.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion description "[In this study, BLyS levels were measured before and after 4 weekly doses of rituximab in 30 patients with previously untreated follicular Grade 1 NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_provenance.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion evidence source_evidence_literature NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_provenance.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion SIO_000772 19051265 NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_provenance.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion wasDerivedFrom befree-20150227 NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_provenance.
- NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_assertion wasGeneratedBy ECO_0000203 NP851332.RAH9F1ZlBnZ0XB34x2XGy1GY6un81_iSXb8K29O_0hX0k130_provenance.